Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Identification of the Microrna Signature of Acute Myeloid Leukemia Patient s Regulatory T Lymphocytes

Redouane Rouas, PhD, Makram Merimi, PhD, Bassam Badram, PhD, Arsene Burny, MD PhD, Dominique Bron, Philippe Lewalle, MD PhD, Hussein Fayyad Kazan, PhD

Blood (2015) 126 (23): 4967.

https://doi.org/10.1182/blood.V126.23.4967.4967

Published: 2015

Journal Articles

Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen

Denis-Claude Roy, MD, Silvy Lachance, MD, Jean Roy, MD, Irwin Walker, MBBS, Johan Maertens, MD PhD, Sandra Cohen, MD, Stephen Ronan Foley, MD, Philippe Lewalle, MD PhD, Eduardo Olavarria, MD PhD, Dominik Selleslag, MD, Manfred Rudiger, Jurjen Velthuis, PhD, Karen Reitsma, PhD, Lisya Gerez, Jeroen Rovers, MDPhD, Halvard Bonig, MD MA, Stephan Mielke, MD

Blood (2015) 126 (23): 4391.

https://doi.org/10.1182/blood.V126.23.4391.4391

Published: 2015

Journal Articles

Long-Term Overall and Event-Free Survival after RIC Allogeneic Transplantation in Acute Leukemias in a Single Centre - Impact of Age and Donor Type?

Sebastian Wittnebel, MD PhD, Philippe Lewalle, MD PhD, Sandra Michiels, Soumaya Anoun, MD, Benjamin Bailly, MD, Marie Vercruyssen, MD, Julie Dallemagne, MD, Sarah Buntinx, MD, Phuong Huynh, MD, Patrick Crombez, Marie France Jaivenois, Dominique Bron, MD PhD

Blood (2015) 126 (23): 5454.

https://doi.org/10.1182/blood.V126.23.5454.5454

Published: 2015

Journal Articles

Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS

Denis-Claude Roy, MD, Johan Maertens, MD PhD, Irwin Walker, MBBS, Silvy Lachance, MD, Jean Roy, MD, Stephen Ronan Foley, MD, Philippe Lewalle, MD PhD, Dominik L.D. Selleslag, MD, Liesbeth De Jong, PhD, Jurjen H.L. Velthuis, PhD, Lisya Gerez, PhD, Karen Reitsma, PhD, Edwin Wagena, PhD, Stephan Mielke, MD

Blood (2014) 124 (21): 314.

https://doi.org/10.1182/blood.V124.21.314.314

Published: 2014

Journal Articles

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Yves Beguin, MD PhD, Pierre Zachee, MD PhD, Johan Maertens, MD PhD, Tessa Kerre, MD PhD, Aurelie Ory, Laurence Seidel, Carlos Graux, MD PhD, Philippe Lewalle, MD PhD, Michel Van Gelder, PhD MD, Koen Theunissen, Evelyne Willems, MD PhD, Marie-Paule Emonds, Ann De Becker, Frederic Baron

Blood (2014) 124 (21): 542.

https://doi.org/10.1182/blood.V124.21.542.542

Published: 2014

NARROW

Identification of the Microrna Signature of Acute Myeloid Leukemia Patient s Regulatory T Lymphocytes

Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen

Long-Term Overall and Event-Free Survival after RIC Allogeneic Transplantation in Acute Leukemias in a Single Centre - Impact of Age and Donor Type?

Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Email alerts

ASH Publications

American Society of Hematology

Identification of the Microrna Signature of Acute Myeloid Leukemia Patient s Regulatory T Lymphocytes

Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen

Long-Term Overall and Event-Free Survival after RIC Allogeneic Transplantation in Acute Leukemias in a Single Centre - Impact of Age and Donor Type?

Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only